Distraction osteogenesis (DO) is a technique that has been widely utilized by surgeons for limb lengthening and in the correction of deformities and nonunions. The two most notable characteristics of this process are that bone is primarily formed by an intramembraneous process and that the new tissues are highly vascularized. In order to test the functional role of vascularization in promoting bone formation and assess the relative importance of the two different vascular endothelial growth factor receptors in mediating vascular tissue and bone formation during DO, we used antibody blockade to both VEGFR1 and VEGFR2 and compared this to single antibody blockade to only VEGFR2.
INTRODUCTION
Distraction osteogenesis (DO) is a technique that has been widely utilized by surgeons for limb lengthening and in the correction of deformities and nonunions. The two most notable characteristics of this process are that bone is primarily formed by an intramembraneous process and that the new tissues are highly vascularized. In order to test the functional role of vascularization in promoting bone formation and assess the relative importance of the two different vascular endothelial growth factor receptors in mediating vascular tissue and bone formation during DO, we used antibody blockade to both VEGFR1 and VEGFR2 and compared this to single antibody blockade to only VEGFR2.
MATERIALS AND METHODS
Materials. Male C57BL/B6 mice were purchased from Jackson Laboratories (Bar Harbor, ME). Distraction osteogenesis devices were obtained from KLS Martin L.P. (Jacksonville, FL). Both anti-VEGF antibodies to VEGFR1 (MF1) and VEGFR2 (DC101) were provided by the ImClone Corporation through a materials transfer agreement.
Surgical, Distraction and Injection Protocols. All animal research was performed under an approved IACUC protocol. The surgical method of murine DO was performed as previously described. Antibodies were delivered by intraperitoneal injections every third day for the duration of the experiment. Dosages were 1.5 mg per injection. Active distraction (0.15 mm/day) was initiated on day 8, after a 7 day latency period. Animals were euthanized one hour after the last distraction.
Molecular Analysis. Tissue samples were collected and mRNA expression was analyzed for the following time points; day 0 (normal bone) day 7 (end of latency), day 10 (latency and 3 days of active distraction), day 17 (latency and 10 days of active distraction), day 20 (latency, active distraction and 3 days of consolidation) and day 31 (latency, active distraction and 14 days of consolidation). Bone formation was assessed by mRNA assay for selective set of extracellular matrix protein mRNA including osteopontin (OPN), bone sialoprotein (BSP), collagen 10 A1, collagen 2 A1 and collagen 1 A1. Expression of various angiogenic receptors including flt1, flk1, Nrp1 and Nrp2 were also assessed across both normal and antibody blockade.
Assessments of Bone and Vascular Formation By µCT. Bone formation and vasculature were assessed by µCT. After removal of the fixators, bones are imaged via µCT at a resolution of 12 µm using a Scanco µCT 40 system (Scanco Medical, Basserdorf, Switzerland). Specimens are immersed in a 60-40 solution of ethyl alcohol and saline during scanning in order to minimize decomposition of the tissue throughout the duration of the scan (~70 minutes). Measurements of total bone volume fraction and mineral density are made directly from the µCT image data of each specimen. Vasculature was imaged by µCT after perfusion with a suspension of lead chromate in silicone rubber (Microfil MV-122, Flow Tech, Carver, MA).
RESULTS
Gross assessments of bone formation were made by Faxitron radiographic analysis of the control, single and double antibody blockade treated animals (Figure1). Robust bone formation and bony bridging were seen by the end of consolidation (day 31) while an intermediate amount of bone formation was observed with the single treatment in comparison to almost complete lack of new bone formation in animals treated with the double antibody blockade. Quantitative assessments of bone formation by micro CT assessments provided a quantitative measure of the gross differences observed by the plain film radiography. Molecular analysis of the anabolic activity of skeletal formation by mRNA expression for various extracellular matrix proteins showed that there was a progressive inhibition in skeletal cell activity with single and double antibody blockade of both VEGFR1 and 2 (Figure 2 ). The expression of both VEGFR1 and 2 were confirmed over the time course of DO by mRNA which showed that both receptors showed an increase beginning in the midphase of distraction after which both remained elevated throughout the period of consolidation. In order to assess the effect of the VEGFR antibody blockade the overall vessel volume and numbers were determined by µCT scanning after Microfil perfusion. These results showed the dramatic effects of the double antibody blockade on vessel formation. A. 
B.

DISCUSSION
These studies demonstrated that both VEGFR1 and VEGFR2 are expressed during DO and reach maximal levels during the consolidation period during which bone formation was the highest. Through the use of anti-VEGFR antibodies we showed that bone formation was dependent on the activities of both receptors. 
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